|
OND Realignment Aims to Improve Review Process
Nearly 220 INDs will be moved March 15 from the Office of New Drugs’ (OND) Division of Anesthesia and Analgesia Products to the Division of Pulmonary
and Allergy Products (DPARP), as part of an OND realignment.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives